Abstract

Glucocorticoid receptors are ligand-activated transcription factors, which play an important role in the brain, mainly in stress response regulation. There are two types of receptors for glucocorticosteroids: mineralocorticoid receptors (MR) with high-affinity for the ligands and glucocorticoid receptors (GR) with a tenfold lower affinity. Selective activation of the receptors during hypoxia may decide neuronal fate, especially in the hippocampus. Depending on the severity of hypoxia-induced damage, neurons undergo necrosis or apoptosis. In the penumbral region, where neurons die mainly through the process of apoptosis, selective GR activation increases excitotoxicity, interferes with apoptotic signalling pathways and causes energy deficit in the cells, all of which promote cell death. On the other hand, selective MR activation seems to be neuroprotective. It is suggested that the main role of MR in neuroprotection is to regulate the balance between anti- and proapoptotic proteins from bcl-2 family.

References

• 1. Ábrahám I.M., Meerlo P., Luiten P.G.: Concentration dependentactions of glucocorticoids on neuronal viability and survival. Dose-Response, 2006; 4: 38–54
  Google Scholar
• 2. Almeida O.F., Condé G.L., Crochemore C., Demeneix B.A., FischerD., Hassan A.H., Meyer M., Holsboer F., Michaelidis T.M.: Subtle shiftsin the ratio between pro- and antiapoptotic molecules after activationof corticosteroid receptors decide neuronal fate. FASEB J.,2000; 14: 779–790
  Google Scholar
• 3. Arnett, M.G., Muglia, L.M., Laryea, G., Muglia, L.J.: Genetic approachesto hypothalamic-pituitary-adrenal axis regulation. Neuropsychopharmacology,2016; 41: 245–260
  Google Scholar
• 4. Avramut M., Achim C.L.: Immunophilins in nervous system degenerationand regeneration. Curr. Top. Med. Chem., 2003; 3: 1376–1382
  Google Scholar
• 5. Beere H.M., Green D.R.: Stress management – heat shock protein- 70 and the regulation of apoptosis. Trends Cell Biol., 2001; 11: 6–10
  Google Scholar
• 6. Bolsover S.R., Hyams J.S., Shephard E.A., White H.A., WiedmannC.G.: Cell Biology, A short course. 2nd edition. John Wiley and Sons,2002
  Google Scholar
• 7. Buckingham J.C.: Glucocorticoids: exemplars of multi-tasking.Br. J. Pharmacol., 2006; 147: S258–S268
  Google Scholar
• 8. Cárdenas S.P., Parra C., Bravo J., Morales P., Lara H.E., Herrera-Marschitz M., Fiedler J.L.: Corticosterone differentially regulatesbax, bcl-2 and bcl-x mRNA levels in the rat hippocampus. Neurosci.Lett., 2002; 331: 9–12
  Google Scholar
• 9. Celsi F., Pizzo P., Brini M., Leo S., Fotino C., Pinton P., Rizzuto R.:Mitochondria, calcium and cell death: A deadly triad in neurodegeneration.Biochim. Biophys. Acta, 2009; 1787: 335–344
  Google Scholar
• 10. Cirulli F., Alleva E.: The NGF saga: From animal models of psychosocialstress to stress-related psychopathology. Front. Neuroendocrinol.,2009; 30: 379–395
  Google Scholar
• 11. Creighton T.E.: Steroid hormone receptors. In: Encyclopedia of MolecularBiology. Ed.: T.E. Creighton. John Wiley & Sons, 1999; 4225–4235
  Google Scholar
• 12. Crochemore C., Lu J., Wu Y., Liposits Z., Sousa N., Holsboer F.,Almeida O.F.: Direct targeting of hippocampal neurons for apoptosisby glucocorticoids is reversible by mineralocorticoid receptoractivation. Mol. Psychiatry, 2005; 10: 790–798
  Google Scholar
• 13. de Kloet E.R., Vreugdenhil E., Oitzl M.S., Jöels M.: Brain corticosteroidsreceptor balance in health and disease. Endocr. Rev., 1998; 19: 269–301
  Google Scholar
• 14. Deshmukh S.S., Knierim J.J.: Hippocampus. Wiley Interdiscip.Rev. Cogn. Sci., 2012; 3: 231–251
  Google Scholar
• 15. Dhuriya Y.K., Sharma D.: Necroptosis: a regulated inflammatorymode of cell death. J. Neuroinflammation, 2018; 15: 199–207
  Google Scholar
• 16. Dinkel K., Ogle W.O., Sapolsky R.M.: Glucocorticoids and centralnervous system inflammation. J. Neurovirol., 2002; 8: 513–528
  Google Scholar
• 17. Dirnagl U., Iadecola C., Moskowitz M.A.: Pathobiology of ischaemicstroke: an integrated view. Trends Neurosci., 1999; 22: 391–397
  Google Scholar
• 18. Elmore S.: Apoptosis: A review of programmed cell death. Toxicol.Pathol., 2007; 35: 495–516
  Google Scholar
• 19. Endres M., Dirnagl U.: Ischemia and stroke. In: Molecular andCellular Biology of Neuroprotection in the CNS. Ed.: Alzheimer C.,Kluwer Academic/Plenum Publishers, 2002; 455–474
  Google Scholar
• 20. Evans R., Mangelsdorf D.: Nuclear receptors, RXR, and the bigbang. Cell, 2014; 157: 255–266
  Google Scholar
• 21. Fanous S., Hammer R.P., Nikulina E.M.: Short- and long-termeffects of intermittent social defeat stress on brain-derived neurotrophicfactor expression in mesocorticolimbic brain regions. Neuroscience,2010; 167: 598–607
  Google Scholar
• 22. Fuller P.J., Yao Y., Yang J., Young M.J.: Mechanisms of ligand specificityof the mineralocorticoid receptor. J. Endocrinol., 2012; 213: 15–24
  Google Scholar
• 23. Gądek-Michalska A., Spyrka J., Rachwalska P., Tadeusz J., BugajskiJ.: Influence of chronic stress on brain corticosteroid receptors andHPA axis activity. Pharmacol. Rep., 2013; 65: 1163–1175
  Google Scholar
• 24. Gems D., Partridge L.: Stress-response hormesis and aging:“That which does not kill us makes us stronger”. Cell Metab, 2008;7: 200-203
  Google Scholar
• 25. Gomez-Sanchez E., Gomez-Sanchez C.E.: The multifaceted mineralocorticoidreceptor. Compr. Physiol., 2014; 4: 965–994
  Google Scholar
• 26. Grad I., Picard D.: The glucocorticoid responses are shaped bymolecular chaperones. Mol. Cell. Endocrinol., 2007; 275: 2–12
  Google Scholar
• 27. Gross K.L., Cidlowski J.A.: Tissue-specific glucocorticoid action:a family affair. Trends Endocrinol. Metab., 2008; 19: 331–339
  Google Scholar
• 28. Harris H.J., Kotelevtsev Y., Mullins J.J., Seckl J.R., Holmes M.C.:Intracellular regeneration of glucocorticoids by 11β-hydroxysteroiddehydrogenase (11β-HSD)-1 plays a key role in regulation of the hypothalamic-pituitary-adrenal axis: analysis of 11β-HSD-1-deficientmice. Endocrinology, 2001; 142: 114–120
  Google Scholar
• 29. Herman J.P., McKlveen J.M., Solomon M.B., Carvalho-Netto E.,Myers B.: Neural regulation of the stress response: glucocorticoidfeedback mechanisms. Brazilian J. Med. Biol. Res., 2012; 45: 292–298
  Google Scholar
• 30. Huang P., Chandra V., Rastinejad F.: Structural overview of thenuclear receptor superfamily: Insights into physiology and therapeutics.Annu. Rev. Physiol., 2010; 72: 247–272
  Google Scholar
• 31. Hwang I.K., Yoo K.Y., Nam Y.S., Choi J.H., Lee I.S., Kwon Y.G.,Kang T.C., Kim Y.S., Won M.H.: Mineralocorticoid and glucocorticoidreceptorexpressions in astrocytes and microglia in thegerbil hippocampalCA1 region after ischemic insult. Neurosci.Res., 2006; 54: 319–327
  Google Scholar
• 32. Jöels M.: Functional actions of corticosteroids in the hippocampus.Eur. J. Pharmacol., 2008; 583: 312–321
  Google Scholar
• 33. Kang P., Rogalska J., Walker C.A., Burke M., Seckl J.R., MacleodM.R., Lai M.: Injury-induced mineralocorticoid receptor expressioninvolves differential promoter usage: A novel role for the rat MRβvariant. Mol. Cell. Endocrinol., 2009; 305: 56–62
  Google Scholar
• 34. Kellendonk C., Gass P., Kretz O., Schütz G., Tronche F.: Corticosteroidreceptors in the brain: gene targeting studies. Brain Res.Bull., 2002; 57: 73–83
  Google Scholar
• 35. Kirschke E., Goswami D., Southworth D., Griffin P.R., Agard D.A.:Glucocorticoid receptor function regulated by coordinatedactionof the Hsp90 and Hsp70 chaperone cycles. Cell, 2014; 157: 1685–1697
  Google Scholar
• 36. Kodama T., Shimizu N., Yoshikawa N., Makino Y., Ouchida R.,Okamoto K., Hisada T., Nakamura H., Morimoto C., Tanaka H.: Roleof the glucocorticoid receptor for regulation of hypoxia-dependentgene expression. J. Biol. Chem., 2003; 278: 33384–33391
  Google Scholar
• 37. Kole A.J., Annis R.P., Deshmukh M.: Mature neurons: equippedfor survival. Cell Death Dis., 2013; 4: e689
  Google Scholar
• 38. Krugers H.J., Maslam S., Korf J., Joëls M., Holsboer F.: The corticosteronesynthesis inhibitor metyrapone prevents hypoxia/ischemia-induced loss of synaptic function in the rat hippocampus. Stroke,2000; 31: 1162–1172
  Google Scholar
• 39. Kumar R., McEwan I.J.: Allosteric modulators of steroid hormonereceptors: Structural dynamics and gene regulation. Endocr.Rev., 2012; 33: 271–299
  Google Scholar
• 40. Lai M., Seckl J., Macleod M.: Overexpression of the mineralocorticoidreceptor protects against injury in PC12 cells. Mol. BrainRes., 2005; 135: 276–279
  Google Scholar
• 41. Lavery D.N., McEwan I.J.: Structure and function of steroid receptorAF1 transactivation domains: Induction of active conformations.Biochem. J., 2005; 391: 449–464
  Google Scholar
• 42. Le Menuet D., Lombès M.: The neuronal mineralocorticoid receptor:From cell survival to neurogenesis. Steroids, 2014; 91: 11–19
  Google Scholar
• 43. Li J., Yuan J.: Cell death in nervous system development andneurological disease. In: Apoptosis. Physiology and Pathology. Ed.:J.C. Reed, D.R. Green, Cambridge University Press, 2011; 123–134
  Google Scholar
• 44. Love S.: Apoptosis and brain ischaemia. Prog. Neuro-PsychopharmacologyBiol. Psychiatry, 2003; 27: 267–282
  Google Scholar
• 45. Macleod M.R., Johansson I.M., Söderström I., Lai M., Gidö G., WielochT., Seckl J.R., Olsson T.: Mineralocorticoid receptor expressionand increased survival following neuronal injury. Eur. J. Neurosci.,2003; 17: 1549–1555
  Google Scholar
• 46. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schütz G.,Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., EvansR.M.: The nuclear receptor superfamily: The second decade. Cell,1995; 83: 835–839
  Google Scholar
• 47. Mathews S.B., Arnold S.E., Epperson C.N.: Hospitalization andcognitive decline: Can the nature of the relationship be deciphered?Am. J. Geriatr. Psychiatry, 2014; 22: 465–480
  Google Scholar
• 48. Mattson M.: Hormesis defined. Ageing Res. Rev., 2008; 7: 1–7
  Google Scholar
• 49. McCullers D.L., Herman J.P.: Mineralocorticoid receptors regulatebcl-2 and p53 mRNA expression in hippocampus. Neuroreport,1998; 9: 3085–3089
  Google Scholar
• 50. McCullers D.L., Sullivan P.G., Scheff S.W., Herman J.P.: Traumaticbrain injury regulates adrenocorticosteroid receptor mRNA levelsin rat hippocampus. Brain Res., 2002; 947: 41–49
  Google Scholar
• 51. McIlwain D.R., Berger T., Mak T.W.: Caspase functions in cell deathand disease. Cold Spring Harb. Perspect. Biol., 2015; 7: a026716
  Google Scholar
• 52. Mifsud K.R., Reul J.M.: Acute stress enhances heterodimerizationand binding of corticosteroid receptors at glucocorticoid target genesin the hippocampus. Proc. Natl. Acad. Sci. USA, 2016; 113: 11336–11341
  Google Scholar
• 53. Mikasova L., Xiong H., Kerkhofs A., Bouchet D., Krugers H.J., Groc L.:Stress hormone rapidly tunes synaptic NMDA receptor through membranedynamics and mineralocorticoid signalling. Sci. Rep., 2017; 7: 8053
  Google Scholar
• 54. Millar L.J., Shi L., Hoerder-Suabedissen A., Molnár Z.: Neonatalhypoxia ischaemia: mechanisms, models, and therapeutic challenges.Front. Cell. Neurosci., 2017; 11: 78
  Google Scholar
• 55. Miyashita T., Krajewski S., Krajewska M., Wang H.G., Lin H.K.,Liebermann D.A., Hoffman B., Reed J.C.: Tumor suppressor p53 is aregulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene,1994; 9: 1799–1805
  Google Scholar
• 56. Morrison R.S., Kinoshita Y., Johnson M.D., Ghatan S., Ho J.T.,Garden G.: Neuronal survival and cell death signaling pathways.Adv. Exp. Med. Biol., 2002; 513: 41–86
  Google Scholar
• 57. Moskowitz M.A., Lo E.H., Iadecola C.: The science of stroke: mechanismsin search of treatments. Neuron, 2010; 67: 181-198
  Google Scholar
• 58. Nagata S.: Apoptosis and clearance of apoptotic cells. Annu. Rev.Immunol., 2018; 36: 489–517
  Google Scholar
• 59. Nishi M., Kawata M.: Dynamics of glucocorticoid receptor andmineralocorticoid receptor: implications from live cell imaging studies.Neuroendocrinology, 2007; 85: 186–192
  Google Scholar
• 60. Odermatt A., Kratschmar D.V.: Tissue-specific modulation ofmineralocorticoid receptor function by 11β-hydroxysteroid dehydrogenases:An overview. Mol. Cell. Endocrinol., 2012; 350: 168–186
  Google Scholar
• 61. Pascual-Le Tallec L., Lombès M.: The mineralocorticoid receptor:A journey exploring its diversity and specificity of action. Mol. Endocrinol.,2005; 19: 2211–2221
  Google Scholar
• 62. Picard D., Yamamoto K.R.: Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor. EMBOJ., 1987; 6: 3333–3340
  Google Scholar
• 63. Rajan V., Edwards C.R., Seckl J.R.: 11β-Hydroxysteroid dehydrogenasein cultured hippocampal cells reactivates inert 11-dehydrocorticosterone,potentiating neurotoxicity. J. Neurosci., 1996; 16: 65–70
  Google Scholar
• 64. Robinson-Rechavi M., Carpentier A.S., Duffraisse M., Laudet V.:How many nuclear hormone receptors are there in the human genome?Trends Genet., 2001; 17: 554–556
  Google Scholar
• 65. Rogalska J.: Mineralocorticoid and glucocorticoid receptors inhippocampus: their impact on neurons survival and behavioral impairmentafter neonatal brain injury. Vitam. Horm., 2010; 82: 391–419
  Google Scholar
• 66. Rogalska J., Caputa M.: Hypometabolism as a strategy of survivalin asphyxiated newborn mammals. Res. Signpost, 2011; 661: 117–145
  Google Scholar
• 67. Rogalska J., Caputa M.: Neonatal asphyxia under hyperthermicconditions alters HPA axis function in juvenile rats. Neurosci. Lett.,2010; 472: 68–72
  Google Scholar
• 68. Rogalska J., Kang P., Wotherspoon W., Macleod M.R., Lai M.: Effectof hyperthermia and anoxia on glucocorticoid and mineralocorticoidreceptor expression in neonatal rat hippocampus. Neurosci. Lett.,2009; 450: 196–200
  Google Scholar
• 69. Roland B.L., Krozowski Z.S., Funder J.W.: Glucocorticoid receptor,mineralocorticoid receptors, 11β-hydroxysteroid dehydrogenase-1and -2 expression in rat brain and kidney: in situ studies. Mol. Cell.Endocrinol., 1995; 111: R1–R7
  Google Scholar
• 70. Sapolsky R.M.: Glucocorticoids and hippocampal atrophy in neuropsychiatricdisorders. Arch. Gen. Psychiatry, 2000; 57: 925–935
  Google Scholar
• 71. Sapolsky R.M., Pulsinelli W.A.: Glucocorticoids potentiateischemicinjury to neurons: therapeutic implications. Science,1985; 229: 1397–1400
  Google Scholar
• 72. Savory J.G., Préfontaine G.G., Lamprecht C., Liao M., WaltherR.F., Lefebvre Y.A., Haché R.J.: Glucocorticoid receptor homodimersand glucocorticoid-mineralocorticoid receptor heterodimers formin the cytoplasm through alternative dimerization interfaces. Mol.Cell. Biol., 2001; 21: 781–793
  Google Scholar
• 73. Uhler T.A., Frim D.M., Pakzaban P., Isacson O.: The effects of megadosemethylprednisolone and U-78517F on toxicity mediated by glutamatereceptors in the rat neostriatum. Neurosurgery, 1994; 34: 122–127
  Google Scholar
• 74. Vandevyver S., Dejager L., Libert C.: Comprehensive overview ofthe structure and regulation of the glucocorticoid receptor. Endocr.Rev., 2014; 35: 671–693
  Google Scholar
• 75. Wyrwoll C.S., Holmes M.C., Seckl J.R.: 11β-Hydroxysteroid dehydrogenasesand the brain: From zero to hero, a decade of progress.Front. Neuroendocrinol., 2011; 32: 265–286
  Google Scholar

Full text